Tech Company M&A Transactions
Calixa Therapeutics Acquisition
Calixa Therapeutics was bought by Cubist Pharmaceuticals. The transaction occurred on 12/14/2009. The transaction price was $92.5 million.
Transaction Overview
Company Name
Acquired By
Announced On
12/14/2009
Transaction Type
M&A
Amount
$92,500,000
M&A Terms
The deal includes a $92.5 up-front cash payment, plus up to $310 million in earnout payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Calixa Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of a novel cephalosporin to address the expanding problem of multi-drug resistant organisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Podlesak
Chief Medical Officer
Ian Friedland
Executive Vice President
James Ge
Vice President
Vernon Jiang
Browse more venture capital transactions:
Prev: 12/14/2009: Getfugu venture capital transaction
Next: 12/14/2009: Flat World Education venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs